Other complications and associated conditions with diabetes in children and adolescents

Pediatric Diabetes

Volumn 10, Issue SUPPL. 12, 2009, Pages 204-210

  Kordonouri, Olga ^a   Maguire, Ann M ^b   Knip, Mikael ^c   Schober, Edith ^d   Lorini, Renata ^e   Holl, Reinhard W ^f   Donaghue, Kim C ^b,g  

^a Children's Hospital Auf der Bult   (Germany)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BECAPLERMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CYCLOSPORIN; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; LEVOTHYROXINE; MINERALOCORTICOID; MYCOPHENOLIC ACID; PROPYLTHIOURACIL; RADIOACTIVE IODINE; STEROID;

ADDISON DISEASE; ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EDEMA; GLYCEMIC CONTROL; GROWTH RETARDATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; JOINT LIMITATION; LIPOATROPHY; LIPODYSTROPHY; LIPOHYPERTROPHY; NECROBIOSIS LIPOIDICA; PRIORITY JOURNAL; PUVA; SIDE EFFECT; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; VITILIGO; WEIGHT GAIN;

ADDISON DISEASE; ADOLESCENT; CELIAC DISEASE; CHILD; DIABETES MELLITUS, TYPE 1; EDEMA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; HYPOTHYROIDISM; INSULIN; JOINT DISEASES; NECROBIOSIS LIPOIDICA; PUBERTY; VITILIGO;

EID: 70350176827     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00573.x     Document Type: Article

References (82)

1. Bognetti E, Riva MC, Bonfanti R, Meschi F, Viscardi M, Chiumello G. Growth changes in children and adolescents with short-term diabetes. Diabetes Care 1998: 21: 1226-1229.
2. Donaghue KC, Kordonouri O, Chan A, Silink M. Secular trends in growth in diabetes: Are we winning? Archives of Disease in Childhood. 2003: 88: 151-154.
3. Gunczler P, Lanes R. Poormetabolic control decreases the growth velocity of diabetic children. Diabetes Care 1999: 22: 1012.
4. Holl RW, Grabert M, Heinze E, Sorgo W, Debatin KM. Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus. European Journal of Pediatrics. 1998: 157: 972-977.
5. Holl RW, HeinzeE, Seifert M, Grabert M, Teller WM. Longitudinal analysis of somatic development in paediatric patients with IDDM: Genetic influences on height and weight. Diabetologia 1994: 37: 925-929.
6. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N.Engl.J.Med. 1993: 329: 977-986.
7. Holl RW, Grabert M, Sorgo W, Heinze E, Debatin KM. Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia 1998: 41: 542-547.
8. Thon A, Heinze E, Feilen KD, Holl RW, Schmidt H, Koletzko S, Wendel U, Nothjunge J. Development of height and weight in children with diabetes mellitus: Report on two prospective multicentre studies, one cross-sectional, one longitudinal. European Journal of Pediatrics 1992: 151: 258-262.
9. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J.Clin.Endocrinol.Metab 2006: 91: 2250-2256.
10. Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001: 358: 221-229.
11. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N.Engl.J.Med. 2004: 350: 2068-2079.
12. Sougioultzoglou F, Falorni A, Kassi G, Brozzetti A, Karamitsos D, Koliakos GG. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes. Exp.Clin.Endocrinol.Diabetes 2005: 113: 85-89.
13. Sumnik Z, Kolouskova S, Malcova H, Vavrinec J, Venhacova J, Lebl J, Cinek O. High prevalence of celiac disease in siblings of children with type 1 diabetes. Eur.J.Pediatr. 2005: 164: 9-12.
14. Hansen D, Bennedbaek FN, Hoier-Madsen M, Hegedus L, Jacobsen BB. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. Eur.J.Endocrinol. 2003: 148: 245-251.
15. Glastras SJ, Craig ME, Verge CF, Chan AK, Cusumano JM, Donaghue KC. The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications. Diabetes Care 2005: 28: 2170-2175.
16. De Block CE, De Leeuw IH, Vertommen JJ, Rooman RP, Du Caju MV, Van Campenhout CM, Weyler JJ, Winnock F, Van Autreve J, Gorus FK, The Belgian DR. Beta-cell, thyroid, gastric, adrenal and celiac autoimmunity and HLA-DQ types in type 1 diabetes. Clinical & Experimental Immunology 2001: 126: 236-241.
17. Holl RW, Bohm B,Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Hormone Research 1999: 52: 113-118.
18. Kontiainen S, Schlenzka A, Koskimies S, Rilva A, Maenpaa J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Research 1990: 13: 151-156.
19. Kordonouri O,Klinghammer A,L ang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: A multicenter survey. Diabetes Care 2002: 25: 1346-1350.
20. Kordonouri O, Hartmann R, Deiss D, Wilms M, Gruters-Kieslich A. Natural course of autoimmune thyroiditis in type 1 diabetes: Association with gender, age, diabetes duration, and puberty. Arch.Dis.Child 2005: 90: 411-414.
21. Umpierrez GE, Latif KA, Murphy MB, Lambeth HC. Stentz: Thyroid Dysfunction in Patients With Type 1 Diabetes: A longitudinal study. Diabetes Care 2003: 26: 1181-1185.
22. Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. Journal of Pediatric Gastroenterology & Nutrition 2001: 33: 462-465.
23. Calero P, Ribes-Koninckx C, Albiach V, Carles C, Ferrer J. IgA antigliadin antibodies as a screening method for nonovert celiac disease in children with insulin-dependent diabetes mellitus. Journal of Pediatric Gastroenterology & Nutrition. 1996: 23: 29-33.
24. Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Lindberg BA, Sjoberg KG, Ivarsson SA. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999: 103: 1248-1252.
25. Crone J, Rami B, Huber WD, Granditsch G, Schober E. Prevalence of Celiac Disease and Follow-up of EMA in Children and Adolescents With Type 1 Diabetes Mellitus. Journal of Pediatric Gastroenterology & Nutrition 2003: 37: 67-71.
26. De V, I, Ghirlanda G, Gasbarrini G. Prevalence of celiac disease in type I diabetes: A multicentre study. Acta Paediatrica Supplement. 1996: 412: 56-57.
27. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Hegedu LS, Jacobsen BB, Husby S. High prevalence of celiac disease in Danish children with type I diabetes mellitus.[comment]. Acta Paediatrica 2001: 90: 1238-1243.
28. Not T, Tommasini A, Tonini G, Buratti E, Pocecco M, Tortul C, Valussi M, Crichiutti G, Berti I, Trevisiol C, Azzoni E, Neri E, Torre G, Martelossi S, Soban M, Lenhardt A, C attin L,Ventura A. Undiagnosed celiac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001: 44: 151-155.
29. Smith CM, Clarke CF, Porteous LE, Elsori H, Cameron DJ. Prevalence of celiac disease and longitudinal follow-up of antigliadin antibody status in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes. 2000: 1 (4): 199-203.
30. Westman E, Ambler GR, Royle M, Peat J, Chan A. Children with celiac disease and insulin dependent diabetes mellitus-growth, diabetes control and dietary intake. Journal of Pediatric Endocrinology & Metabolism 1999: 12: 433-442.
31. Saukkonen T, Vaisanen S, Akerblom HK, Savilahti E, Childhood Diabetes in Finland Study Group. Celiac disease in children and adolescents with type 1 diabetes: A study of growth, glycaemic control, and experiences of families. Acta Paediatrica 2002: 91: 297-302.
32. Mohn A, Cerruto M, Lafusco D, Prisco F, Tumini S, Stoppoloni O, Chiarelli F. Celiac disease in children and adolescents with type I diabetes: Importance of hypoglycemia. Journal of Pediatric Gastroenterology & Nutrition 2001: 32: 37-40.
33. Tesei N, Sugai E, Vazquez H, Smecuol E, Niveloni S, Mazure R, Moreno ML, Gomez JC, Maurino E, Bai JC. Antibodies to human recombinant tissue transglutaminase may detect celiac disease patients undiagnosed by endomysial antibodies. Alimentary Pharmacology & Therapeutics 2003: 17: 1415-1423.
34. Lenhardt A, Plebani A, Marchetti F, Gerarduzzi T, Not T, Meini A, Villanacci V, Martelossi S, Ventura A. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of celiac disease in patients with selective immunoglobulin A deficiency. Dig.Liver Dis. 2004: 36: 730-734.
35. Cataldo F, Marino V, Bottaro G, Greco P, Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997: 131: 306-308.
36. Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin.Gastroenterol. 1995: 9: 273-293.
37. Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002: 25: 1117-1122.
38. Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Celiac disease in children and adolescents with IDDM: Clinical characteristics and response to gluten-free diet. Diabetic Medicine 1998: 15: 38-44.
39. Corazza GR, Di Sario A, Cecchetti L, Jorizzo RA, Di Stefano M, Minguzzi L, Brusco G, Bernardi M, Gasbarrini G. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult celiac disease. Bone 1996: 18: 525-530.
40. Fabiani E, Catassi C, Villari A, Gismondi P, Pierdomenico R, Ratsch IM, Coppa GV, Giorgi PL. Dietary compliance in screening-detected celiac disease adolescents. Acta Paediatrica Supplement 1996: 412: 65-67.
41. Mustalahti K, Collin P, Sievanen H, Salmi J, Maki M. Osteopenia in patients with clinically silent celiac disease warrants screening. Lancet 1999: 354: 744-745.
42. Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Youngerage at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: An Italian multicenter study. Diabetes Care 2004: 27: 1294-1298.
43. Larsson K, Carlsson A, Cederwall E, Jonsson B, Neiderud J, Jonsson B, Lernmark A, Ivarsson SA, Skane Study Group. Annual screening detects celiac disease in children with type 1 diabetes. Pediatric Diabetes. 2008: 9 (4 Pt 2): 354-9.
44. Handa S, Dogra S, Epidemiology of childhood vitiligo: A study of 625 patients from north India. Pediatric Dermatology 2003: 20: 207-210.
45. Verrotti A, Chiarelli F, Amerio PL, Morgese G. Skin diseases in children with type 1 diabetes mellitus. Journal of the European Academy of Dermatology and Venereology 1995: 4: 41-43.
46. Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clinical & Experimental Immunology 1997: 107: 341-346.
47. Peterson P, Salmi H, Hyoty H, Miettinen A, Ilonen J, Reijonen H, Knip M, Akerblom HK, Krohn K. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clinical Immunology & Immunopathology 1997: 82: 37-42.
48. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21. Nat.Genet. 1994: 8: 83-87.
49. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N.Engl.J.Med. 1990: 322: 1829-1836.
50. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. J.Clin.Endocrinol.Metab 2003: 88: 2983-2992.
51. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J.Clin.Invest 2000: 106: R75-R81.
52. Ampudia-Blasco FJ, Girbes J, Carmena R. A case of lipoatrophy with insulin glargine: Long-acting insulin analogs are not exempt from this complication. Diabetes Care 2005: 28: 2983.
53. Ampudia-Blasco FJ,Hasbum B, Carmena R. A New Case Of Lipoatrophy With Lispro Insulin In Insulin Pump Therapy: Is there any insulin preparation free of complications? Diabetes Care 2003: 26: 953.
54. Griffin ME, Feder A, Tamborlane WV. Lipoatrophy Associated With Lispro Insulin in Insulin Pump Therapy: An old complication, a new cause? Diabetes Care 2001: 24: 174.
55. Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Experimental & Clinical Endocrinology & Diabetes 1996: 104: 106-110.
56. Kordonouri O, Lauterborn R, Deiss D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care 2002: 25: 634.
57. Saez-de-Ibarra L, Gallego F. Factors related to lipohypertrophy in insulin-treated diabetic patients: Role of educational intervention. Practical Diabetes International 1998: 15: 9-11.
58. Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, Lins PE. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care 2005: 28: 2025-2027.
59. Thow JC, Johnson AB, Marsden S, Taylor R, Home PD. Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin. Diabetic Medicine 1990: 7: 795-799.
60. De Silva BD, Schofield OMV, Walker JD. The prevalence of necrobiosis lipoidica diabeticorum in children with type 1 diabetes. British Journal of Dermatology 1999: 141: 593-594.
61. Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: Association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabetic Medicine 1993: 10: 725-728.
62. Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis lipoidica diabeticorum in children and adolescents: A clue for underlying renal and retinal disease. Pediatric Dermatology 1995: 12: 220-223.
63. Boyd AS. Tretinoin treatment of necrobiosis lipoidica diabeticorum. Diabetes Care 1999: 22: 1753-1754.
64. D'Argento V, Curatolli G,Filotico R, Foti C, Vena GA. Cyclosporin A in the treatment of necrobiosis lipoidica diabeticorum. Journal of Dermatological Treatment 1997: 8: 123-125.
65. Evans AV, Atherton DJ. Recalcitrant ulcers in necrobiosis lipoidica diabeticorum healed by topical granulocyte-macrophage colony-stimulating factor. British Journal of Dermatology 2002: 147: 1023-1025.
66. Ling TC, Thomson KF, Goulden V, Goodfield MJ. PUVA therapy in necrobiosis lipoidica diabeticorum. Journal of the American Academy of Dermatology 2002: 46: 319-320.
67. Moreno-Arias GA, Camps-Fresneda A. Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser. Journal of Cosmetic & Laser Therapy 2001: 3: 143-146.
68. Nguyen K, Washenik K, Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. Journal of the American Academy of Dermatology 2002: 46: S34-S36.
69. Stephens E RJGP. Becaplermin and necrobiosis lipoidicum diabeticorum: results of a case control pilot study. Journal of Diabetes & its Complications 2001: 15: 55-56.
70. Tidman M. Management of necrobiosis lipoidica. Clinical & Experimental Dermatology 2002: 27: 328-337.
71. Grgic A, Rosenbloom AL,Weber FT, Giordano B, Malone JI, Shuster JJ. Joint contracture-common manifestation of childhood diabetes mellitus. J.Pediatr. 1976: 88: 584-588.
72. Rosenbloom AL, Silverstein JH, Lezotte DC, Riley WJ, Maclaren NK. Limited joint mobility in diabetes mellitus of childhood: Natural history and relationship to growth impairment. J.Pediatr. 1982: 101: 874-878.
73. Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N.Engl.J.Med. 1981: 305: 191-194.
74. Hanna W, Friesen D, Bombardier C, Gladman D, Hanna A. Pathologic features of diabetic thick skin. J.Am.Acad.Dermatol. 1987: 16: 546-553.
75. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N.Engl.J.Med. 1986: 314: 403-408.
76. Garg SK, Chase HP, Marshall G, Jackson WE, Holmes D, HoopsS, Harris S. Limited joint mobility in subjects with insulin dependent diabetes mellitus: Relationship with eye and kidney complications. Archives of Disease in Childhood 1992: 67: 96-99.
77. Starkman HS, Gleason RE, Rand LI, Miller DE, Soeldner JS. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: Relation to chronic complications. Ann.Rheum.Dis. 1986: 45: 130-135.
78. Silverstein JH, Gordon G, Pollock BH, Rosenbloom AL. Long-term glycemic control influences the onset of limited joint mobility in type 1 diabetes. J.Pediatr. 1998: 132: 944-947.
79. Infante JR, Rosenbloom AL, Silverstein JH, Garzarella L, Pollock BH. Changes in frequency and severity of limited joint mobility in children with type 1 diabetes mellitus between 1976-78 and 1998. Journal of Pediatrics 2001: 138: 33-37.
80. Lindsay JR, Kennedy L, Atkinson AB, Bell PM, Carson DJ, McCance DR, Hunter SJ. Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year period. Diabetes Care 2005: 28: 658-661.
81. Hirshberg B, Muszkat M, Marom T, Shalit M. Natural course of insulin edema. Journal of Endocrinological Investigation 2000: 23: 187-188.
82. Wheatley T, Edwards OM. Insulin oedema and its clinical significance: metabolic studies in three cases. Diabetic Medicine 1985: 2: 400-404.